Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

被引:19
|
作者
Chinwong, Dujrudee [1 ,2 ]
Patumanond, Jayanton [3 ]
Chinwong, Surarong [1 ]
Siriwattana, Khanchai [4 ]
Gunaparn, Siriluck [5 ]
Hall, John Joseph [6 ]
Phrommintikul, Arintaya [5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmaceut Care, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Clin Epidemiol Program, Chiang Mai 50200, Thailand
[3] Thammasat Univ, Fac Med, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand
[4] Nakornping Hosp, Div Med, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50200, Thailand
[6] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
关键词
LDL-C goal attainment; statins; potency statins; high risk; propensity score; LIPID-LOWERING TREATMENT; HIGH-RISK; HYPERCHOLESTEROLEMIC PATIENTS; LDL-C; MEDICATION ADHERENCE; CLINICAL-PRACTICE; PROPENSITY SCORE; ACHIEVEMENT; SIMVASTATIN; EZETIMIBE;
D O I
10.2147/TCRM.S75608
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand. Methods: A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of. 70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication. Results: Of 396 ACS patients (60% males, mean age 64.3 +/- 11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363). Conclusion: There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [1] Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
    Wang, Qinqin
    Liang, Chun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (06) : 658 - 670
  • [2] Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naive acute coronary syndrome
    Im, Jihaeng
    Kawada-Watanabe, Erisa
    Yamaguchi, Junichi
    Arashi, Hiroyuki
    Otsuki, Hisao
    Matsui, Yuko
    Sekiguchi, Haruki
    Fujii, Shinya
    Mori, Fumiaki
    Ogawa, Hiroshi
    Hagiwara, Nobuhisa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis
    Lee, Jayden
    Egolum, Ugochukwu
    Parihar, Harish
    Cooley, Michael
    Ling, Hua
    CARDIOLOGY RESEARCH, 2021, 12 (02) : 98 - 108
  • [4] Statin therapy and low-density lipoprotein cholesterol reduction after acute coronary syndrome: Insights from the United Arab Emirates
    Shehab, Abdulla
    Bhagavathula, Akshaya Srikanth
    HEART VIEWS, 2020, 21 (02): : 80 - 87
  • [5] LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENT AMONG MALAYSIAN DYSLIPIDEMIC PATIENTS
    AL-khateeb, Alyaa
    Mohamed, Mohd Sapawi
    Imran, Kamarul
    Ibrahim, Suhairi
    Zilfalil, B. A., I
    Yusof, Zurkurnai
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (02) : 388 - 394
  • [6] Combination Therapy With Ezetimibe/Simvastatin Versus Statin Monotherapy for Low-Density Lipoprotein Cholesterol Reduction and Goal Attainment in a Real-World Clinical Setting
    Friedman, Howard S.
    Rajagopalan, Srinivasan
    Barnes, Jaime P.
    Roseman, Hal
    CLINICAL THERAPEUTICS, 2011, 33 (02) : 212 - 224
  • [7] High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome
    Fang, Ming
    Qian, Qiaohui
    Zhao, Zhihong
    Zhu, Luoning
    Su, Jinwen
    Li, Xinming
    INTERNATIONAL HEART JOURNAL, 2018, 59 (02) : 300 - 306
  • [8] Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence
    Lee, Jeongmin
    Lee, Sue Hyun
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    Kim, Ju Han
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (01) : 134 - 142
  • [9] Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
    Ballantyne, Christie M.
    McKenney, James M.
    MacDougall, Diane E.
    Margulies, Janice R.
    Robinson, Paula L.
    Hanselman, Jeffrey C.
    Lalwani, Narendra D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (12) : 1928 - 1933
  • [10] Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II
    Buddhari, Wacin
    Uerojanaungkul, Preecha
    Sriratanasathavorn, Charn
    Sukonthasarn, Apichard
    Ambegaonkar, Baishali
    Brudi, Philippe
    Horack, Martin
    Lautsch, Dominik
    Vyas, Ami
    Gitt, Anselm K.
    HEART LUNG AND CIRCULATION, 2020, 29 (03) : 405 - 413